Riskpilot← Back to searchSign inGet full accessPharmaLundensis AB
ABActiveOrg 5567088074Scheelevägen 22Research and experimental development on natural sciences and engineering · NACE 7210Est. 20061-4 employees
Revenue 2024
SEK 0
EBITDA margin
—
+23% vs 2023
Equity ratio
38.5%
Financial strength
Net profit 2024
SEK -3,6M
+18% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -2,2M | +23% |
| Net profit | SEK -3,6M | +18% |
| Total assets | SEK 10,1M | -8% |
| Equity | SEK 3,9M | +23% |
| Employees | — | — |
Legal name
PharmaLundensis AB
Org number
5567088074
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
17 augusti 2006
Share capital
SEK 2 527 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Skogvall, Tord Staffan Håkan
Company purpose
Bolaget skall bedriva utveckling, marknadsföring och försäljning av läkemedel, utveckling, marknadsföring och försäljning av produkter för vattenrening samt bedriva annan därmed förenlig verksamhet.
Address
Scheelevägen 22
Phone
+4646132778
Email
staffan.skogvall@pharmalundensis.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −2 613 | −2 198 | −2 615 | −2 859 | −2 188 |
| Depreciation & amort. | −247 | −0 | −211 | −1 028 | −1 088 |
| EBIT | −2 860 | −2 198 | −2 826 | −3 887 | −3 276 |
| Net financials | −336 | −411 | −459 | −513 | −351 |
| Profit before tax | −3 195 | −2 609 | −3 286 | −4 400 | −3 627 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −3 195 | −2 609 | −3 286 | −4 400 | −3 627 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 664 | 8 309 | 8 760 | 10 963 | 10 072 |
| Equity | 2 948 | 3 198 | 1 757 | 3 159 | 3 882 |
| Long-term debt | 3 768 | 4 179 | 4 638 | 5 151 | 1 667 |
| Short-term debt | 947 | 932 | 2 366 | 2 653 | 4 522 |
| Total debt | 4 715 | 5 111 | 7 004 | 7 804 | 6 189 |
EBITDA margin
-218800000.0%
This company
15.8%
Market median
-1384810227% vs market
20202024
Equity ratio
38.5%
This company
38.2%
Market median
+1% vs market
20202024
Return on equity
-93.4%
This company
18.4%
Market median
-608% vs market
20202024
Net profit margin
-362700000.0%
This company
8.1%
Market median
-4477777878% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.59×
This company
0.62×
Market median
-156% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TS Chief Executive Officer | Chief Executive Officer | 2020 |
PM Audit | Audit | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2025 | |
| Deputy Board Member | 2020 | |
| Former (3) | ||
| Chairman | 2020 – 2025 | |
| Board of Directors | 2020 – 2020 | |
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PharmaLundensis AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tord Staffan Håkan Skogvall | Chief Executive Officer | 0 companies |
| Per Martin Bengtsson | Audit | 0 companies |
| Stefan Rolf Ahlfors | Board of Directors | 0 companies |
| Bo David Sten Wennergren | Board of Directors | 0 companies |
| Tord Arne Gunnar Skogvall | Chairman | 0 companies |
| Björn Torsten Georg Sivik | Chairman | 0 companies |
| Sten Jonas Erjefält | Board of Directors | 0 companies |
| Astrid Ingela A Skogvall Svensson | Board of Directors | 0 companies |
| Jan Anders Persson | Deputy Board Member | 0 companies |